Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining

Jing Zhuang, Fan Li, Xuan Liu, Zhiping Liu, Jianxian Lin, Yihong Ge, Joseph Michael Kaminski, James Bradley Summers, Zhichong Wang, Jian Ge, Keming Yu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Lithium chloride is a therapeutic agent for treatment of bipolar affective disorders. Increasing numbers of studies have indicated that lithium has neuroprotective effects. However, the molecular mechanisms underlying the actions of lithium have not been fully elucidated. This study aimed to investigate whether lithium chloride produces neuroprotective function by improving DNA repair pathway in retinal neurocyte. In vitro, the primary cultured retinal neurocytes (85.7% are MAP-2 positive cells) were treated with lithium chloride, then cultured with serum-free media to simulate the nutrient deprived state resulting from ischemic insult. The neurite outgrowth of the cultured cells increased significantly in a dose-dependent manner when exposed to different levels of lithium chloride. Genomic DNA electrophoresis demonstrated greater DNA integrity of retinal neurocytes when treated with lithium chloride as compared to the control. Moreover, mRNA and protein levels of Ligase IV (involved in DNA non-homologous end-joining (NHEJ) pathway) in retinal neurocytes increased with lithium chloride. The end joining activity assay was performed to determine the role of lithium on NHEJ in the presence of extract from retinal neurocytes. The rejoining levels in retinal neurocytes treated with lithium were significantly increased as compared to the control. Furthermore, XRCC4, the Ligase IV partner, and the transcriptional factor, CREB and CTCF, were up-regulated in retinal cells after treating with 1.0 mM lithium chloride. Therefore, our data suggest that lithium chloride protects the retinal neural cells from nutrient deprivation in vitro, which may be similar to the mechanism of cell death in glaucoma. The improvement in DNA repair pathway involving in Ligase IV might have an important role in lithium neuroprotection. This study provides new insights into the neural protective mechanisms of lithium chloride.

Original languageEnglish (US)
Pages (from-to)650-654
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume380
Issue number3
DOIs
StatePublished - Mar 13 2009

Fingerprint

DNA End-Joining Repair
Lithium Chloride
Joining
Nutrients
Food
DNA
Lithium
Ligases
Cells
DNA Repair
Repair
Serum-Free Culture Media
Neuroprotective Agents
Cell death
Electrophoresis
Mood Disorders
Bipolar Disorder
Glaucoma
Cultured Cells
Assays

Keywords

  • Ligase IV
  • Lithium chloride
  • NHEJ
  • Neuroprotection
  • Retinal neuron

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining. / Zhuang, Jing; Li, Fan; Liu, Xuan; Liu, Zhiping; Lin, Jianxian; Ge, Yihong; Kaminski, Joseph Michael; Summers, James Bradley; Wang, Zhichong; Ge, Jian; Yu, Keming.

In: Biochemical and Biophysical Research Communications, Vol. 380, No. 3, 13.03.2009, p. 650-654.

Research output: Contribution to journalArticle

Zhuang, J, Li, F, Liu, X, Liu, Z, Lin, J, Ge, Y, Kaminski, JM, Summers, JB, Wang, Z, Ge, J & Yu, K 2009, 'Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining', Biochemical and Biophysical Research Communications, vol. 380, no. 3, pp. 650-654. https://doi.org/10.1016/j.bbrc.2009.01.162
Zhuang, Jing ; Li, Fan ; Liu, Xuan ; Liu, Zhiping ; Lin, Jianxian ; Ge, Yihong ; Kaminski, Joseph Michael ; Summers, James Bradley ; Wang, Zhichong ; Ge, Jian ; Yu, Keming. / Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining. In: Biochemical and Biophysical Research Communications. 2009 ; Vol. 380, No. 3. pp. 650-654.
@article{5454887e5b274d97a31d94183088ec38,
title = "Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining",
abstract = "Lithium chloride is a therapeutic agent for treatment of bipolar affective disorders. Increasing numbers of studies have indicated that lithium has neuroprotective effects. However, the molecular mechanisms underlying the actions of lithium have not been fully elucidated. This study aimed to investigate whether lithium chloride produces neuroprotective function by improving DNA repair pathway in retinal neurocyte. In vitro, the primary cultured retinal neurocytes (85.7{\%} are MAP-2 positive cells) were treated with lithium chloride, then cultured with serum-free media to simulate the nutrient deprived state resulting from ischemic insult. The neurite outgrowth of the cultured cells increased significantly in a dose-dependent manner when exposed to different levels of lithium chloride. Genomic DNA electrophoresis demonstrated greater DNA integrity of retinal neurocytes when treated with lithium chloride as compared to the control. Moreover, mRNA and protein levels of Ligase IV (involved in DNA non-homologous end-joining (NHEJ) pathway) in retinal neurocytes increased with lithium chloride. The end joining activity assay was performed to determine the role of lithium on NHEJ in the presence of extract from retinal neurocytes. The rejoining levels in retinal neurocytes treated with lithium were significantly increased as compared to the control. Furthermore, XRCC4, the Ligase IV partner, and the transcriptional factor, CREB and CTCF, were up-regulated in retinal cells after treating with 1.0 mM lithium chloride. Therefore, our data suggest that lithium chloride protects the retinal neural cells from nutrient deprivation in vitro, which may be similar to the mechanism of cell death in glaucoma. The improvement in DNA repair pathway involving in Ligase IV might have an important role in lithium neuroprotection. This study provides new insights into the neural protective mechanisms of lithium chloride.",
keywords = "Ligase IV, Lithium chloride, NHEJ, Neuroprotection, Retinal neuron",
author = "Jing Zhuang and Fan Li and Xuan Liu and Zhiping Liu and Jianxian Lin and Yihong Ge and Kaminski, {Joseph Michael} and Summers, {James Bradley} and Zhichong Wang and Jian Ge and Keming Yu",
year = "2009",
month = "3",
day = "13",
doi = "10.1016/j.bbrc.2009.01.162",
language = "English (US)",
volume = "380",
pages = "650--654",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining

AU - Zhuang, Jing

AU - Li, Fan

AU - Liu, Xuan

AU - Liu, Zhiping

AU - Lin, Jianxian

AU - Ge, Yihong

AU - Kaminski, Joseph Michael

AU - Summers, James Bradley

AU - Wang, Zhichong

AU - Ge, Jian

AU - Yu, Keming

PY - 2009/3/13

Y1 - 2009/3/13

N2 - Lithium chloride is a therapeutic agent for treatment of bipolar affective disorders. Increasing numbers of studies have indicated that lithium has neuroprotective effects. However, the molecular mechanisms underlying the actions of lithium have not been fully elucidated. This study aimed to investigate whether lithium chloride produces neuroprotective function by improving DNA repair pathway in retinal neurocyte. In vitro, the primary cultured retinal neurocytes (85.7% are MAP-2 positive cells) were treated with lithium chloride, then cultured with serum-free media to simulate the nutrient deprived state resulting from ischemic insult. The neurite outgrowth of the cultured cells increased significantly in a dose-dependent manner when exposed to different levels of lithium chloride. Genomic DNA electrophoresis demonstrated greater DNA integrity of retinal neurocytes when treated with lithium chloride as compared to the control. Moreover, mRNA and protein levels of Ligase IV (involved in DNA non-homologous end-joining (NHEJ) pathway) in retinal neurocytes increased with lithium chloride. The end joining activity assay was performed to determine the role of lithium on NHEJ in the presence of extract from retinal neurocytes. The rejoining levels in retinal neurocytes treated with lithium were significantly increased as compared to the control. Furthermore, XRCC4, the Ligase IV partner, and the transcriptional factor, CREB and CTCF, were up-regulated in retinal cells after treating with 1.0 mM lithium chloride. Therefore, our data suggest that lithium chloride protects the retinal neural cells from nutrient deprivation in vitro, which may be similar to the mechanism of cell death in glaucoma. The improvement in DNA repair pathway involving in Ligase IV might have an important role in lithium neuroprotection. This study provides new insights into the neural protective mechanisms of lithium chloride.

AB - Lithium chloride is a therapeutic agent for treatment of bipolar affective disorders. Increasing numbers of studies have indicated that lithium has neuroprotective effects. However, the molecular mechanisms underlying the actions of lithium have not been fully elucidated. This study aimed to investigate whether lithium chloride produces neuroprotective function by improving DNA repair pathway in retinal neurocyte. In vitro, the primary cultured retinal neurocytes (85.7% are MAP-2 positive cells) were treated with lithium chloride, then cultured with serum-free media to simulate the nutrient deprived state resulting from ischemic insult. The neurite outgrowth of the cultured cells increased significantly in a dose-dependent manner when exposed to different levels of lithium chloride. Genomic DNA electrophoresis demonstrated greater DNA integrity of retinal neurocytes when treated with lithium chloride as compared to the control. Moreover, mRNA and protein levels of Ligase IV (involved in DNA non-homologous end-joining (NHEJ) pathway) in retinal neurocytes increased with lithium chloride. The end joining activity assay was performed to determine the role of lithium on NHEJ in the presence of extract from retinal neurocytes. The rejoining levels in retinal neurocytes treated with lithium were significantly increased as compared to the control. Furthermore, XRCC4, the Ligase IV partner, and the transcriptional factor, CREB and CTCF, were up-regulated in retinal cells after treating with 1.0 mM lithium chloride. Therefore, our data suggest that lithium chloride protects the retinal neural cells from nutrient deprivation in vitro, which may be similar to the mechanism of cell death in glaucoma. The improvement in DNA repair pathway involving in Ligase IV might have an important role in lithium neuroprotection. This study provides new insights into the neural protective mechanisms of lithium chloride.

KW - Ligase IV

KW - Lithium chloride

KW - NHEJ

KW - Neuroprotection

KW - Retinal neuron

UR - http://www.scopus.com/inward/record.url?scp=60549095577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549095577&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.01.162

DO - 10.1016/j.bbrc.2009.01.162

M3 - Article

C2 - 19285016

AN - SCOPUS:60549095577

VL - 380

SP - 650

EP - 654

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -